Rhythm Pharmaceuticals In... (RYTM)
Rhythm Pharmaceuticals Max Pain By Strike
RYTM trades at $101.2, 12.4% above the near-term max pain of $90 expiring Sep 19, 2025 (23 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($50-$90), reflecting growing call interest at higher strikes. Key magnetic zone at 90 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Rhythm Pharmaceuticals Max Pain By Expiry
Max pain for RYTM shows an upward trend from 50 to 90, suggesting bullish positioning in longer-dated options. The 52% spread signals divergent expectations across timeframes. Most levels below 101.2 may cap rallies. Strong magnetic level at 90 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 90 | -11.20 (-11.07%) |
| Oct 17, 2025 | 90 | -11.20 (-11.07%) |
| Nov 21, 2025 | 90 | -11.20 (-11.07%) |
| Dec 19, 2025 | 50 | -51.20 (-50.59%) |
| Jan 16, 2026 | 65 | -36.20 (-35.77%) |
| Apr 17, 2026 | 75 | -26.20 (-25.89%) |